CHANNEL 11 REPORTS ON ENDOTHELIX AND ITS CUTTING-EDGE HEART RESEARCH IN COLLABORATION WITH UNIVERSITY OF HOUSTON
HOUSTON, TX. (August 25, 2006) Endothelix Inc, a Houston Technology Center Client, and its founder’s pioneering research were the focus of Houston’s Channel 11 Up Close this week.
In its program titled “Do you have a healthy heart?” CBS local affiliate, KHOU showed Houston-based researchers are leading an international collaborative effort to advance early detection and prevention of heart attack. The project called SHAPE (Screening for Heart Attack Prevention and Education) is led by Dr. Morteza Naghavi and has received attention nationwide. Dr. Naghavi, is the founder of Endothelix and a former director of the Vulnerable Plaque Research Center at the Texas Heart Institute and University of Texas Health Science Center in Houston. The program also presented a prospective view of Endothelix’s low-cost, non-invasive VENDYS™ test, a new technology for screening vascular health by monitoring temperature changes at one’s fingertips. The test works much like a blood pressure measurement and measures vascular reactivity which is surrogate marker of endothelial dysfunction.
“If independent tests prove the device effective, millions could be inexpensively checked for early signs of heart disease,” broadcasted KHOU.
Endothelix has been recently named the recipient of a $1 million award by the State of Texas’s Emerging Technology Fund.
“We are proud to develop innovative technologies for preventive cardiology” said Dr. Naghavi. “Prevention must come first. Treatment after the heart attack struck is like locking the barn door after the horse is stolen. Unfortunately, more than 50% of heart attack victims die within one hour”.
Two of Endothelix collaborators at the University of Houston, Dr. Ralph Metcalfe, professor of biomedical engineering, and Dr. Ioannis Kakadiaris, professor of biomedical computer science, were also featured in the Channel 11 program. “Our collaboration with the Texas Medical Center and Endothelix is very promising,” said Dr. Metcalfe.
“For me it’s a personal mission; my mother died of a heart attack,” said Dr. Kakadiaris.
To view the Channel 11 Up Close, click on:
Endothelix is dedicated to bringing endothelial function measurement from research laboratories to the mainstream practice of medicine in a low-cost and operator-independent manner. Endothelial dysfunction is associated with several diseases such as cardiovascular disease, diabetes, renal failure, Alzheimer’s disease, and more. The immediate focus of the company is on early detection of cardiovascular disease and monitoring response to therapy. More information is available at www.endothelix.com.
About the University of Houston
The University of Houston, Texas’ premier metropolitan research and teaching institution, is home to more than 40 research centers and institutes and sponsors more than 300 partnerships with corporate, civic and governmental entities. UH, the most diverse research university in the country, stands at the forefront of education, research and service with more than 35,000 students.
The Computational Biomedicine Laboratory of UH is leading advanced cardiovascular imaging technologies aiming at early detection and prevention of heart disease. www.uh.edu
About Houston Technology Center
Houston Technology Center (HTC) is a business accelerator that assists Houston-based emerging technology companies in key sectors such as: Energy, Information Technology, Life Sciences, Nanotechnology and NASA-originated technologies. See www.houstontech.org for more information. www.HoustonTech.org
# # #